Taken together with evidence of PP2A upregulation in DCM, these results provide impetus for the establishment of an AAV9sc.PBD translational pipeline for the treatment of this disease, including the testing of AAV9sc.PBD in additional models of DCM based upon different genetic mutations. Here, PTPA is linked to familial dilated cardiomyopathy.